N@N

CUTR, PRA, SNTS, ARRY, VECO, OTTR Expected To Be Up After Next Earnings Releases

May 3, 2013 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Monday, May 6th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. Cutera Inc (NASDAQ:CUTR), ProAssurance Corp (NYSE:PRA), Santarus Inc (NASDAQ:SNTS), Array Biopharma Inc (NASDAQ:ARRY), Veeco Instruments Inc (NASDAQ:VECO), Otter Tail Corp (NASDAQ:OTTR) are all expected to be Up After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up After earnings are released Monday:

  Symbol  Company                          # of Reports         Quarter  Release Time
  CUTR    Cutera Inc                       6 Quarter            Q1       After
  PRA     ProAssurance Corp                May Earnings         Q1       After
  SNTS    Santarus Inc                     6 Quarter            Q1       After
  ARRY    Array Biopharma Inc              6 Quarter            Q3       After
  VECO    Veeco Instruments Inc            6 Quarter            Q4       After
  OTTR    Otter Tail Corp                  6 Quarter            Q1       After

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

Cutera Inc (NASDAQ:CUTR) - Cutera, Inc., a global medical device company, engages in the research, design, development, manufacture, marketing, sales, and service of laser and light-based systems for aesthetic and podiatric applications worldwide. It offers a range of non-invasive laser and intense pulsed light products for use in the treatment of cosmetic vascular conditions, pigmented lesions, skin rejuvenation, hair removal, acne, scar revision, and onychomycosis (nail fungus). The company primarily serves dermatologists, plastic surgeons, gynecologists, family practitioners, primary care physicians, physicians offering aesthetic treatments in non-medical offices, and other qualified practitioners. It sells and markets its products through a network of direct sales representatives and distributors. The company was founded in 1998 and is headquartered in Brisbane, California..

ProAssurance Corp (NYSE:PRA) - ProAssurance Corporation, through its subsidiaries, provides medical and other professional liability insurance products to individuals and institutions engaged in the delivery of healthcare in the United States. The company also offers legal professional liability insurance services. It primarily serves physicians, dentists, chiropractors, optometrists, and allied health professionals, as well as medical technology and life sciences companies. The company markets its products through independent agencies and brokers, as well as an internal sales force. ProAssurance Corporation was founded in 1976 and is based in Birmingham, Alabama..

Santarus Inc (NASDAQ:SNTS) - Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. The company sells metformin hydrochloride extended release tablets under the Glumetza name and bromocriptine mesylate tablets under the CYCLOSET name, which are indicated to treat type 2 diabetes; fenofibrate tablets under Fenoglide name that is used to treat primary hyperlipidemia or mixed dyslipidemia; and omeprazole/sodium bicarbonate capsules and powder for oral suspension under Zegerid name for the treatment of upper GI conditions, including gastroesophageal reflux disease. Its products under development include budesonide MMX, which is in Phase IIIb clinical studies for the induction of remission of mild to moderate active ulcerative colitis; Rhucin (recombinant human C1 inhibitor) under Phase III clinical studies for the treatment of acute attacks of hereditary angioedema; Rifamycin SV MMX, a semi-synthetic antibiotic, which is in Phase III clinical studies for the treatment of travelers diarrhea; and SAN-300 under Phase I clinical study for the treatment of rheumatoid arthritis. Santarus, Inc. has strategic alliance agreements with Merck & Co., Inc.; GlaxoSmithKline, plc.; and Cosmo Technologies Limited. The company was founded in 1996 and is headquartered in San Diego, California..

Array Biopharma Inc (NASDAQ:ARRY) - Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases primarily in North America, Europe, and the Asia Pacific. Its proprietary clinical programs include ARRY-520, a Kinesin spindle protein inhibitor, which is in Phase II clinical trial for patients with multiple myeloma; ARRY-614, a p38/Tie2 dual inhibitor that is in Phase I clinical trial for the treatment of myelodysplastic syndromes; ARRY-797, a p38 inhibitor, which is in Phase II clinical trial for pain; and ARRY-502, a CRTh2 antagonist that is in Phase II clinical trial for asthma. The company s partnered clinical programs comprise Selumetinib and AZD8330, and MEK162 and MEK300 MEK inhibitors, which are in Phase II clinical trials for the treatment of cancer; Danoprevir, a hepatitis C virus protease inhibitor that is in Phase II trial; AMG 151, a glucokinase activator, which is in Phase II trial for type 2 diabetes; ARRY-543/ASLAN001, a HER2/EGFR inhibitor that is in Phase II clinical trial for gastric cancer; and GDC-0068, a AKT inhibitor, which is in Phase II trial for cancer. Its partnered clinical programs also include LY2603618, a Chk-1 inhibitor that is in Phase II trial for cancer; GDC-0575 and GDC-0425 Chk-1 inhibitors, which are in Phase Ib trial for cancer; ARRY-382, a cFMS inhibitor that is in Phase I trial for cancer; and VTX-2337, a toll-like receptor, which is in Phase Ib trial for cancer. The company has collaborations with Amgen Inc.; ASLAN Pharmaceuticals Pte Ltd.; AstraZeneca, PLC; Celgene Corporation; Genentech Inc.; Novartis International Pharmaceutical Ltd.; Roche Holding AG; Eli Lilly and Company; and VentiRx Pharmaceuticals, Inc. for the development and commercialization of the partnered drugs. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado..

Veeco Instruments Inc (NASDAQ:VECO) - Veeco Instruments Inc., together with its subsidiaries, designs, manufactures, and markets various equipments to make light emitting diodes (LEDs) and hard-disk drives worldwide. The company s LED and Solar segment designs and manufactures metal organic chemical vapor deposition and molecular beam epitaxy systems and components for the manufacturers of LEDs, wireless devices, power semiconductors, and concentrator photovoltaics, as well as to research and development applications. Its Data Storage segment designs and manufactures various technologies, including ion beam etch, ion beam deposition, diamond-like carbon, physical vapor deposition, chemical vapor deposition, and slicing, dicing, and lapping systems to create thin film magnetic heads that read and write data on hard disk drives. The company was founded in 1945 and is headquartered in Plainview, New York..

Otter Tail Corp (NASDAQ:OTTR) - Otter Tail Corporation engages in electric and nonelectric operations primarily in the United States, Canada, and Mexico. It operates in five segments: Electric, Wind Energy, Manufacturing, Construction, and Plastics. The Electric segment produces, transmits, distributes, and sells electric energy. It provides electricity to approximately 129,000 customers in a 50,000 square mile area of Minnesota, North Dakota, and South Dakota. This segment also acts as a wholesale participant in the Midwest Independent Transmission System Operator markets; and offers technical and engineering services. The Wind Energy segment produces wind towers and other heavy metal fabricated products. The Manufacturing segment manufactures metal components primarily for the recreational vehicle, agricultural, lawn and garden, industrial equipment, health and fitness, and enclosure industries; and manufactures and fabricates parts for off-road equipment, mining machinery, oil fields, offshore oil rigs, wind industry components, broadcast antennae, and farm equipment for various equipment manufacturers. It also produces and markets residential and commercial waterfront equipment, including boatlifts, docks, and full marina systems; thermoformed products for the horticulture industry; and clamshell packing, blister packs, returnable pallets, and handling trays for shipping and storing odd-shaped or difficult-to-handle parts. The Construction segment offers mechanical and prime contracting services for water and wastewater treatment plants, power generation plants, hospital and pharmaceutical facilities, and other industrial and manufacturing projects; and electrical design and construction services for the industrial, commercial, and municipal business markets. The Plastics segment produces PVC pipes for municipal water, rural water, wastewater, storm drainage systems, water reclamation systems, and other uses. The company was founded in 1907 and is based in Fergus Falls, Minnesota..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources

---